This activation is likely a consequence of increased levels of TNF-α, IL-6, ICAM-1, CRP, and other inflammatory-immune markers observed in AD patients’ serum (Figure 3) [151,153,154]. This evidence concerns the gene TNF and Alzheimer disease.